LMNX Luminex Corporation Stock Quote

LMNX [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	134.64	EPS (ttm)	0.22	Insider Own	0.20%	Shs Outstand	45.46M	Perf Week	6.11%
Market Cap	1.41B	Forward P/E	28.30	EPS next Y	1.06	Insider Trans	-56.45%	Shs Float	44.24M	Perf Month	6.41%
Income	10.40M	PEG	8.98	EPS next Q	0.14	Inst Own	92.10%	Short Float	6.85%	Perf Quarter	31.27%
Sales	380.80M	P/S	3.70	EPS this Y	-190.70%	Inst Trans	-4.81%	Short Ratio	5.05	Perf Half Y	12.92%
Book/sh	11.35	P/B	2.63	EPS next Y	16.94%	ROA	2.50%	Target Price	33.50	Perf Year	13.39%
Cash/sh	6.54	P/C	4.57	EPS next 5Y	15.00%	ROE	3.50%	52W Range	20.61 - 41.69	Perf YTD	29.28%
Dividend	0.40	P/FCF	-	EPS past 5Y	-17.60%	ROI	-2.80%	52W High	-28.30%	Beta	0.55
Dividend %	1.34%	Quick Ratio	5.00	Sales past 5Y	8.10%	Gross Margin	57.80%	52W Low	45.03%	ATR	1.88
Employees	1247	Current Ratio	6.40	Sales Q/Q	34.80%	Oper. Margin	6.60%	RSI (14)	53.47	Volatility	9.64% 6.37%
Optionable	Yes	Debt/Eq	0.39	EPS Q/Q	131.70%	Profit Margin	4.50%	Rel Volume	1.07	Prev Close	31.59
Shortable	Yes	LT Debt/Eq	0.39	Earnings	Feb 08 AMC	Payout	95.50%	Avg Volume	600.07K	Price	29.89
Recom	2.60	SMA20	2.17%	SMA50	9.71%	SMA200	7.51%	Volume	643,179	Change	-5.38%

Aug-18-20

Resumed

Piper Sandler

Overweight

$38

Sep-27-19

Downgrade

JP Morgan

Neutral → Underweight

$23 → $21

Jan-05-18

Initiated

BTIG Research

Buy

$24

Jan-18-17

Initiated

Deutsche Bank

Sell

$18

Oct-12-16

Initiated

Avondale

Mkt Outperform

$27

Aug-18-16

Upgrade

JP Morgan

Underweight → Neutral

Aug-04-15

Upgrade

Wedbush

Neutral → Outperform

Nov-05-13

Reiterated

UBS

Neutral

$24 → $21.50

Jul-30-13

Downgrade

UBS

Buy → Neutral

$22 → $24

Aug-23-12

Upgrade

UBS

Neutral → Buy

$25 → $22

Jul-31-12

Downgrade

William Blair

Outperform → Mkt Perform

May-01-12

Reiterated

UBS

Neutral

$22 → $25

Mar-12-10

Initiated

Jefferies & Co

Buy

$20

Nov-18-09

Initiated

William Blair

Mkt Perform

May-08-09

Reiterated

Wedbush Morgan

Buy

$26 → $28

Apr-14-09

Initiated

Piper Jaffray

Neutral

Dec-12-08

Downgrade

Leerink Swann

Outperform → Mkt Perform

Oct-16-08

Initiated

UBS

Neutral

Oct-10-08

Initiated

Cowen & Co

Neutral

Aug-08-08

Reiterated

Canaccord Adams

Buy

$24 → $26

Mar-02-21 09:44AM	Here's Why You Should Retain Luminex (LMNX) Stock for Now Zacks -5.38%
Feb-19-21 07:54AM	Luminex Secures BARDA Funding To Develop And Validate Flu/COVID-19 Combo Respiratory Panel Benzinga -5.70%
06:30AM	Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel PR Newswire
Feb-16-21 06:04AM	Roubaix Capitals Short Bet on Luminex Corp. (LMNX) Pays Off Insider Monkey
Feb-14-21 01:32PM	15 Best Small-Cap Healthcare Stocks to Buy Insider Monkey
Feb-09-21 11:47PM	Luminex Corporation Just Missed Earnings - But Analysts Have Updated Their Models Simply Wall St. -7.98%
09:59AM	Luminex (LMNX) Q4 Earnings Miss Estimates, Revenues Beat Zacks
04:30AM	Luminex Corp (DE) (LMNX) Q4 2020 Earnings Call Transcript Motley Fool
Feb-08-21 05:35PM	Luminex (LMNX) Q4 Earnings Miss Estimates Zacks
04:20PM	Recap: Luminex Q4 Earnings Benzinga
04:01PM	Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results PR Newswire
01:00PM	Luminex Corporation Declares First Quarter Cash Dividend PR Newswire
Feb-05-21 10:11AM	Luminex's Earnings: A Preview Benzinga
Feb-01-21 02:36AM	Investors Who Bought Luminex (NASDAQ:LMNX) Shares Five Years Ago Are Now Up 55% Simply Wall St.
Jan-27-21 07:00AM	Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 PR Newswire
Jan-13-21 11:14AM	Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-12-21 06:00AM	Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue PR Newswire
Dec-21-20 10:14AM	Ex-Dividend Date Insight: Luminex Benzinga
Dec-16-20 11:39PM	Luminex Corporation (NASDAQ:LMNX) Will Pay A US$0.10 Dividend In Four Days Simply Wall St.
02:23PM	Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-10-20 01:57AM	These 4 Measures Indicate That Luminex (NASDAQ:LMNX) Is Using Debt Reasonably Well Simply Wall St.
Dec-07-20 10:59AM	Luminex Corporation Declares Fourth Quarter Cash Dividend PR Newswire
Dec-05-20 11:32AM	Why Is Luminex (LMNX) Down 0.8% Since Last Earnings Report? Zacks
Nov-10-20 08:07AM	Luminex (LMNX) Declines 6.6% as Q3 Earnings Miss Estimates Zacks
Nov-05-20 11:32PM	Luminex Corp (DE) (LMNX) Q3 2020 Earnings Call Transcript Motley Fool
04:02PM	Luminex Corporation Reports Strong Third Quarter 2020 Results PR Newswire
Oct-29-20 12:35PM	Luminex (LMNX) Earnings Expected to Grow: Should You Buy? Zacks
Oct-26-20 10:37AM	Calculating The Intrinsic Value Of Luminex Corporation (NASDAQ:LMNX) Simply Wall St.
Oct-22-20 07:00AM	Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020 PR Newswire
Oct-07-20 07:00AM	Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue PR Newswire -5.89%
Sep-28-20 08:02PM	Hedge Funds Have Never Been This Bullish On Luminex Corporation (LMNX) Insider Monkey
08:22AM	Here's Why You Should Retain Luminex (LMNX) Stock for Now Zacks
Sep-24-20 04:05PM	Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2 PR Newswire
08:15AM	The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO Benzinga
04:58AM	Luminex Wins US Award For Covid-19 Antibody Test Project SmarterAnalyst
Sep-23-20 04:05PM	Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test PR Newswire
Sep-18-20 06:02AM	It Might Not Be A Great Idea To Buy Luminex Corporation (NASDAQ:LMNX) For Its Next Dividend Simply Wall St.
Sep-15-20 07:30AM	Luminex Corporation Declares Third Quarter Cash Dividend PR Newswire
Sep-03-20 11:31AM	Luminex (LMNX) Down 34.6% Since Last Earnings Report: Can It Rebound? Zacks -5.66%
Aug-28-20 09:42AM	Is Luminex Corporation's (NASDAQ:LMNX) Recent Price Movement Underpinned By Its Weak Fundamentals? Simply Wall St.
Aug-27-20 12:39PM	Why Co-Diagnostics, GenMark, Luminex, and Opko Stocks Are Sinking Today Motley Fool -11.81%
Aug-26-20 08:30AM	Here's Why You Should Retain Luminex (LMNX) Stock for Now Zacks
Aug-05-20 09:08AM	Luminex (LMNX) Q2 Earnings Beat Estimates, Revenues Miss Zacks
02:01AM	Luminex Corp (DE) (LMNX) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 06:25PM	Luminex (LMNX) Q2 Earnings Surpass Estimates Zacks
05:39PM	Luminex Scores Relative Strength Rating Upgrade Investor's Business Daily
04:36PM	Luminex: Q2 Earnings Insights Benzinga
04:15PM	Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors PR Newswire
04:01PM	Luminex Corporation Reports Second Quarter 2020 Results PR Newswire
Jul-28-20 12:33PM	Luminex (LMNX) Earnings Expected to Grow: Should You Buy? Zacks
Jul-22-20 05:00AM	Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 PR Newswire
Jul-21-20 08:13AM	Luminex (LMNX) Receives EUA for New COVID-19 Antibody Test Zacks
Jul-20-20 01:16PM	Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020 PR Newswire
07:17AM	Luminex's stock rises on FDA authorization for antibody test MarketWatch
05:00AM	Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test PR Newswire
Jul-17-20 11:40AM	Update: Luminex (NASDAQ:LMNX) Stock Gained 95% In The Last Five Years Simply Wall St. +5.07%
Jul-16-20 10:06AM	Luminex (LMNX) Catches Eye: Stock Jumps 7.1% Zacks
Jul-13-20 10:07AM	Here's Why You Should Retain Luminex (LMNX) Stock for Now Zacks
Jul-08-20 09:46AM	Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue PR Newswire
07:00AM	Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue PR Newswire
Jul-06-20 09:28AM	Luminex Boosts Product Portfolio With New xMAP Technology Zacks
Jul-01-20 05:00AM	Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners PR Newswire
Jun-30-20 09:37AM	Luminex Expands COVID-19 Testing With New Antibody Test Zacks +7.97%
Jun-29-20 04:01PM	Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test PR Newswire
Jun-28-20 05:23PM	Luminex Corporation (LMNX): Hedge Funds Cashing Out Insider Monkey
Jun-03-20 11:30AM	Why Is Luminex (LMNX) Down 18.5% Since Last Earnings Report? Zacks
May-28-20 04:52PM	Edited Transcript of LMNX earnings conference call or presentation 4-May-20 9:00pm GMT Thomson Reuters StreetEvents -5.21%
10:33AM	Luminex Sees Hammer Chart Pattern: Time to Buy? Zacks
May-26-20 10:34AM	How Luminex (LMNX) Stock Stands Out in a Strong Industry Zacks
May-22-20 07:00AM	Luminex Corporation Declares Second Quarter Cash Dividend PR Newswire
May-20-20 08:44AM	Surging Earnings Estimates Signal Good News for Luminex (LMNX) Zacks
May-12-20 08:06PM	Were Hedge Funds Right About Luminex Corporation (LMNX)? Insider Monkey
12:56PM	Zacks.com featured highlights include: Acacia, Virtu and Luminex Zacks
May-11-20 08:44AM	Did Luminex Corporation (NASDAQ:LMNX) Insiders Buy Up More Shares? Simply Wall St.
May-08-20 03:55PM	Why Luminex Shares Are Tumbling 13.5% Today Motley Fool -14.38%
07:00AM	Luminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025 PR Newswire
May-07-20 08:54AM	New Strong Buy Stocks for May 7th Zacks
May-05-20 09:41AM	Luminex (LMNX) Q1 Earnings Miss Estimates, Revenues Beat Zacks +6.47%
May-04-20 09:31PM	Luminex Corp (DE) (LMNX) Q1 2020 Earnings Call Transcript Motley Fool
Apr-30-20 09:33AM	Should You Buy Luminex Corporation (LMNX) Ahead of Earnings? Zacks
Apr-22-20 08:30AM	Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020 PR Newswire
Apr-17-20 09:12AM	3 MedTech Stocks Likely to Have Braved Coronavirus Blow in Q1 Zacks
Apr-14-20 07:58AM	Here's Why You Should Hold on to Luminex (LMNX) Stock Now Zacks
Apr-07-20 08:23AM	Luminex (LMNX) Receives EUA for Coronavirus Detection Test Zacks +5.21%
Apr-06-20 04:30PM	Luminex Corporation Pre-Release of 1st Quarter Revenue PR Newswire
07:30AM	Luminex Receives FDA Emergency Use Authorization for ARIES® SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease PR Newswire
Mar-31-20 07:30AM	Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test PR Newswire
Mar-30-20 11:13AM	Luminex (LMNX) Receives EUA for Coronavirus Detection Test Zacks
Mar-27-20 04:05PM	Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease PR Newswire
07:45AM	Is Luminex Corporation's (NASDAQ:LMNX) CEO Paid At A Competitive Rate? Simply Wall St.
Mar-17-20 09:02AM	Austin companies at forefront of race to boost coronavirus testing American City Business Journals +9.90%
Mar-13-20 07:30AM	Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts PR Newswire +15.29%
Mar-11-20 11:30AM	Luminex (LMNX) Up 13.2% Since Last Earnings Report: Can It Continue? Zacks
Mar-04-20 09:33AM	Luminex Hits a New 52-Week High: What's Driving the Stock? Zacks
07:30AM	Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus PR Newswire
Mar-02-20 08:27AM	Luminex Files for FDA 510(k) Clearance of RSP Flex Assay Zacks +6.46%
Mar-01-20 09:00PM	Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance PR Newswire
Feb-24-20 09:00AM	Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance PR Newswire
Feb-18-20 11:57AM	Luminex Corporation Declares First Quarter Cash Dividend PR Newswire
Feb-17-20 05:31AM	Edited Transcript of LMNX earnings conference call or presentation 10-Feb-20 10:00pm GMT Thomson Reuters StreetEvents

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CURRIE HARRISS T	SVP, Finance & CFO	Mar 01	Option Exercise	18.26	5,325	97,235	231,142	Mar 01 04:31 PM
CURRIE HARRISS T	SVP, Finance & CFO	Mar 01	Sale	32.35	5,325	172,262	226,868	Mar 01 04:31 PM
Bennett Todd C.	SVP, Global Sales & Cust Ops	Feb 25	Option Exercise	19.09	121,507	2,319,018	155,640	Mar 01 04:33 PM
Bennett Todd C.	SVP, Global Sales & Cust Ops	Feb 25	Sale	34.06	121,507	4,138,088	34,197	Mar 01 04:33 PM
Eck Stephen L.	Director	Nov 25	Buy	22.40	4,487	100,501	37,807	Nov 30 11:26 AM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 05	Option Exercise	15.93	11,176	178,034	44,329	Aug 05 06:55 PM
SHAMIR NACHUM	President & CEO	Aug 05	Option Exercise	15.93	8,559	136,345	197,583	Aug 05 06:56 PM
Shapiro Eric	SR VP, GLOBAL MARKETING	Aug 05	Option Exercise	16.74	14,179	237,356	48,046	Aug 06 09:24 AM
Shapiro Eric	SR VP, GLOBAL MARKETING	Aug 05	Sale	40.16	14,179	569,429	33,867	Aug 06 09:24 AM
Fairchild Nancy	SVP, Human Resources	Aug 05	Sale	40.16	24,283	975,205	33,828	Aug 06 09:22 AM
SHAMIR NACHUM	President & CEO	Aug 05	Sale	40.16	8,559	343,729	189,632	Aug 05 06:56 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 05	Sale	40.93	11,176	457,434	33,153	Aug 05 06:55 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 04	Option Exercise	15.93	3,786	60,311	36,939	Aug 05 06:55 PM
SHAMIR NACHUM	President & CEO	Aug 04	Option Exercise	15.93	116,441	1,854,905	305,465	Aug 05 06:56 PM
LOEWENBAUM G WALTER II	Director	Aug 04	Sale	39.02	50,000	1,951,030	450,441	Aug 06 01:08 PM
SHAMIR NACHUM	President & CEO	Aug 04	Sale	39.50	116,441	4,599,420	189,024	Aug 05 06:56 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 04	Sale	38.93	3,786	147,389	33,153	Aug 05 06:55 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 03	Option Exercise	15.93	7,389	117,707	40,542	Aug 05 06:55 PM
SHAMIR NACHUM	President & CEO	Aug 03	Option Exercise	15.93	125,000	1,991,250	314,024	Aug 05 06:56 PM
SHAMIR NACHUM	President & CEO	Aug 03	Sale	38.51	125,000	4,813,138	189,024	Aug 05 06:56 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Aug 03	Sale	38.93	7,389	287,654	33,153	Aug 05 06:55 PM
Fairchild Nancy	SVP, Human Resources	Jul 21	Option Exercise	18.54	69,282	1,284,299	95,786	Jul 21 06:48 PM
Fairchild Nancy	SVP, Human Resources	Jul 21	Sale	37.85	69,282	2,622,324	58,111	Jul 21 06:48 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Jul 17	Option Exercise	15.93	11,175	178,018	43,984	Jul 17 09:02 PM
Myers Randall	SVP, Global Mfg and Quality	Jul 17	Option Exercise	20.02	41,200	824,773	52,359	Jul 20 08:14 PM
Fairchild Nancy	SVP, Human Resources	Jul 17	Option Exercise	19.13	50	957	58,161	Jul 20 08:13 PM
Collins Charles J.	SR VP, R&D - US	Jul 17	Option Exercise	18.64	22,748	423,917	47,897	Jul 20 08:13 PM
Collins Charles J.	SR VP, R&D - US	Jul 17	Sale	37.00	22,748	841,676	34,554	Jul 20 08:13 PM
Fairchild Nancy	SVP, Human Resources	Jul 17	Sale	37.85	50	1,893	58,111	Jul 20 08:13 PM
Myers Randall	SVP, Global Mfg and Quality	Jul 17	Sale	37.50	41,200	1,545,000	33,588	Jul 20 08:14 PM
Rew Richard W. II	SVP, Gen Counsel & Corp Secy	Jul 17	Sale	36.93	11,175	412,693	33,153	Jul 17 09:02 PM
Fairchild Nancy	SVP, Human Resources	Jul 15	Option Exercise	17.11	56,525	967,145	90,264	Jul 17 10:52 AM
Collins Charles J.	SR VP, R&D - US	Jul 15	Option Exercise	15.93	37,252	593,424	71,462	Jul 17 10:52 AM
LOEWENBAUM G WALTER II	Director	Jul 15	Sale	34.96	50,000	1,748,010	709,415	Jul 17 10:52 AM
LOEWENBAUM G WALTER II	Director	Jul 15	Sale	35.90	50,000	1,794,915	500,441	Jul 17 10:52 AM
Collins Charles J.	SR VP, R&D - US	Jul 15	Sale	34.50	37,252	1,285,298	34,554	Jul 17 10:52 AM
Fairchild Nancy	SVP, Human Resources	Jul 15	Sale	36.01	56,525	2,035,240	58,111	Jul 17 10:52 AM
Fairchild Nancy	SVP, Human Resources	Jul 06	Option Exercise	16.42	23,475	385,494	77,424	Jul 07 10:46 AM
Fairchild Nancy	SVP, Human Resources	Jul 06	Sale	33.00	23,475	774,675	57,424	Jul 07 10:46 AM
LOEWENBAUM G WALTER II	Director	Jul 06	Sale	33.00	26,347	869,382	759,415	Jul 07 05:38 PM
LOEWENBAUM G WALTER II	Director	Jul 02	Sale	32.86	15,800	519,152	785,762	Jul 06 08:17 AM
LOEWENBAUM G WALTER II	Director	Jul 01	Sale	32.88	7,853	258,244	801,562	Jul 06 08:17 AM
LOEWENBAUM G WALTER II	Director	Jun 05	Sale	30.69	44,495	1,365,600	809,415	Jun 05 10:59 AM
LOEWENBAUM G WALTER II	Director	Jun 04	Sale	31.02	55,505	1,721,798	853,910	Jun 05 10:59 AM
Myers Randall	SVP, Global Mfg and Quality	May 26	Option Exercise	18.11	75,000	1,358,162	77,543	May 27 09:53 AM
Myers Randall	SVP, Global Mfg and Quality	May 26	Sale	31.05	75,000	2,328,600	33,588	May 27 09:53 AM
LOEWENBAUM G WALTER II	Director	May 22	Sale	31.27	86,657	2,709,756	543,460	May 26 11:51 AM
SHAMIR NACHUM	President & CEO	Apr 16	Option Exercise	21.10	125,000	2,637,500	314,024	Apr 16 11:26 AM
SHAMIR NACHUM	President & CEO	Apr 16	Sale	31.00	125,000	3,875,000	189,024	Apr 16 11:26 AM
SHAMIR NACHUM	President & CEO	Apr 15	Option Exercise	21.10	79,092	1,668,841	268,116	Apr 16 11:26 AM
SHAMIR NACHUM	President & CEO	Apr 15	Sale	30.00	79,092	2,372,760	189,024	Apr 16 11:26 AM
SHAMIR NACHUM	President & CEO	Apr 14	Option Exercise	21.10	45,908	968,659	234,932	Apr 16 11:26 AM
SHAMIR NACHUM	President & CEO	Apr 14	Sale	30.00	45,908	1,377,240	189,024	Apr 16 11:26 AM
CURRIE HARRISS T	SVP, Finance & CFO	Mar 09	Option Exercise	16.55	11,217	185,641	222,913	Mar 10 05:09 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience